John Mayer

Company: Ambrosia Biosciences

Job title: Chief Scientific Officer

Seminars:

Comparing Oral vs. Injectable Delivery for Patient Preference & Adherence to Broaden Treatment Accessibility for Greater Patient Choice 2:40 pm

Assessing patient convenience factors for ease of administration to improve treatment adherence for more consistent therapeutic effects Evaluating bioavailability and absorption profiles for consistent drug exposure to ensure predictable efficacy for reliable patient responses Considering cost-effectiveness and reimbursement for wider patient access to reduce financial barriers for broader population reach Read more

day: Day One